Awakn Life Sciences Corp.: Awakn Life Sciences Reports Q4 2023 and Annual Results

Annual Revenue Increased by 534%
Toronto, Ontario--(Newsfile Corp. - April 28, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics

Related Keywords

Norway ,Toronto ,Ontario ,Canada ,London ,City Of ,United Kingdom ,Exeter ,Devon ,Oslo ,United States ,Canadian ,Gordo Whittaker ,Catalent Zydis ,Anthony Tennyson ,Linkedin Facebook ,Awakn Bristol ,Newsfile Corp ,National Institute For Health ,Awakn Life Sciences Corp ,Research Council ,University Of Exeter ,International Financial Reporting Standards ,United Kingdom National Health Services ,Awakn Life Sciences ,Regulatory Agency ,Care Research ,Annual Revenue Increased ,Life Sciences ,Alcohol Use Disorder ,Oral Disintegrating Tablet ,Operational Updates ,Including Subsequent Updates ,Innovation Passport ,Innovative Licensing ,Access Pathway ,Severe Alcohol Use ,National Health Services ,National Institute ,Medical Research Council ,Clinics Trondheim ,Corporate Highlights ,Including Subsequent Developments ,Financial Highlights ,United States Securities Act ,Awakn Life ,Awakn ,Life ,Ciences ,Orp ,Reports ,023 ,Nnual ,Results ,